- Vouliez-vous dire
- pannis, pieter
Résultats de la recherche - 13 results
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients
Publication Type: Peer reviewed scientific article Authors: Nicolas Gemander; Delphine Kemlin; Stéphanie Depickère; Natasha S. Kelkar; Shilpee Sharma; Pieter Pannus; Alexandra Waegemans; Véronique ...
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.
Depickère; Alexia Charles; Maria Goossens; Leen Vandermosten; I Desombere; Kevin K Ariën; Pieter Pannus; Christiane Knoop; Arnaud Marchant Source: J Heart Lung Transplant (2024) Abstract: Lung transplant ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Publication Type: Peer reviewed scientific article Authors: Kemlin, Delphine; Gemander, Nicolas; Stéphanie Depickère; Olislagers, Véronique; Georges, Daphnée; Waegemans, Alexandra; Pannus, Pieter ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Goossens; Pieter Pannus; Ariën, Kevin K; Sébastien Anguille; Annelies Janssens; Hans Prenen; Evelien L J Smits; Christof Vulsteke; Eva Lion; Peeters, ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Publication Type: Peer reviewed scientific article Authors: Frédéric Baron; Lorenzo Canti; Ariën, Kevin K; Delphine Kemlin; I Desombere; Margaux Gerbaux; Pieter Pannus; Yves Beguin; Arnaud Marchant; ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; Sven De Keersmaecker; Yana Debie; Manon Huizing; Pieter Pannus; Kristof Y Neven; Ariën, Kevin K; Geert A Martens; Marc Van den Bulcke; Ella Roelant; ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial (poster)
Publication Type: Scientific poster, presentation or proceeding Authors: Pieter Pannus; Stéphanie Depickère; Delphine Kemlin; Sarah Houben; Christophe Y. Neven; Leo Hendrickx; Johan Michiels; ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Publication Type: Peer reviewed scientific article Authors: Lorenzo Canti; Ariën, Kevin K; I Desombere; Stéphanie Humblet-Baron; Pieter Pannus; Heyndrickx, Leo; Aurélie Henry; Sophie Servais; ...
Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19.
Orte Cano; Véronique Del Marmol; Pieter Pannus; Frédérick Libert; Sven Saussez; Nicolas Dauby; Jishnu Das; Arnaud Marchant; Stanislas Goriely Source: JCI Insight, Volume 7, Issue 9 (2022) Keywords: ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
Publication Type: Peer reviewed scientific article Authors: Ariën, Kevin K; Heyndrickx, Leo; Johan Michiels; Katleen Vereecken; Kurt Van Lent; Sandra Coppens; Betty Willems; Pieter Pannus; Geert ...